Trials / Sponsors / Celcuity Inc
Celcuity Inc
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Bre Breast Cancer | Phase 3 | 2025-07-24 |
| Recruiting | Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, Urogenital Diseases, Male | Phase 1 / Phase 2 | 2024-01-01 |
| Active Not Recruiting | Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients Wit Breast Cancer | Phase 3 | 2022-12-08 |
| Completed | A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letroz Breast Cancer | Phase 1 | 2016-06-14 |
| Available | Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009 Breast Neoplasm Malignant Female | — | — |